Diomed Developments Limited

Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565
WWW: http://www.dermal.co.uk

Summary of Product Characteristics last updated on the eMC: 14/05/2010
SPC Adios Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-May-2010
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 4.5 (Interaction with other medicinal products and other forms of interaction) : the text has changed from "None known" to "Adios can theoretically have an effect on anticoagulant treatments.  Closer monitoring of such patients by their doctor/clinic is advised if they take Adios."

In section 10 (Date of Revision of the Text) : the date has changed to "May 2010"
Updated on 10/06/2008 and displayed until 14/05/2010
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   01-Apr-2008
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 4.4 (Special warnings and precautions for use), the following text has been added: "Because it contains lactose and sucrose, patients with rare hereditary problems of galactose or fructose intolerance, glucose-galactose malabsorption, the Lapp lactase deficiency or sucrose-isomaltase insufficiency should not take this medicine".

In section 6.5 (Nature and contents of container), the following text has been removed: "This is supplied as an original pack (OP)".

In section 10 (Date of revision of the text), the date has changed to "1 April 2008".
Updated on 24/07/2007 and displayed until 10/06/2008
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   05/2007
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 9: "Renewal of the Authorisation" date has changed to 11 May 2007.
Updated on 26/01/2007 and displayed until 24/07/2007
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   butternut
   dandelion root
   dry extract boldo
   dry extract fucus